Is the 9-valent human papillomavirus vaccine (Gardasil 9) contraindicated during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

HPV Nine-Valent Vaccine (Gardasil 9) is Contraindicated During Pregnancy

The 9-valent HPV vaccine should not be administered during pregnancy, though inadvertent exposure does not appear to cause harm and is not an indication for pregnancy termination. 1, 2

Current Contraindication Status

The FDA drug label explicitly states that "safety and effectiveness of GARDASIL 9 have not been established in pregnant women" 2. The most recent ACOG guidelines (2026) clearly list HPV vaccine as contraindicated during pregnancy in their maternal immunization table 1. However, the vaccine can be initiated while breastfeeding and postpartum 1.

What Happens with Inadvertent Exposure

Despite the contraindication, the safety data from inadvertent exposures are reassuring:

  • Pregnancy registry data (2014-2021): Among 70 prospectively enrolled pregnancies with known outcomes, there were 66 live births (95.7%), 3 miscarriages (4.3%), and 3 major birth defects (4.5%) 3. These rates are consistent with background population rates.

  • FDA label data: Analysis of 62 pregnancies exposed within 30 days of vaccination showed a 27.4% miscarriage rate (compared to 12.7% in controls receiving quadrivalent HPV vaccine), but 0% major birth defects among live births 2. A larger five-year registry of 1,640 pregnancies showed 6.8% miscarriage rate and 2.4% major birth defects—both within expected background rates 2.

  • VAERS surveillance: Among 82 pregnancy reports (2014-2017), most (73.2%) reported no adverse events, with only 3 spontaneous abortions (3.7%) 4.

Clinical Management Algorithm

If a patient is discovered to be pregnant:

  1. Stop the vaccination series immediately until after pregnancy completion
  2. Do not terminate the pregnancy based on inadvertent vaccine exposure
  3. Counsel the patient that available data are reassuring regarding pregnancy outcomes
  4. Encourage registry enrollment by calling 1-800-986-8999 2
  5. Resume vaccination postpartum or while breastfeeding 1

Before each vaccination dose:

  • Screen for pregnancy with history and/or testing as appropriate
  • Defer vaccination if pregnancy is detected 2

Important Caveats

The contraindication exists primarily because efficacy and safety have not been formally established in controlled trials during pregnancy—not because of demonstrated harm 2. The distinction is critical for counseling patients who were inadvertently exposed. Both patients and providers express significant uncertainty about HPV vaccine safety in pregnancy and desire more research before feeling comfortable with antepartum administration 5.

The vaccine can and should be offered immediately postpartum or during breastfeeding to complete the series and provide protection before subsequent pregnancies 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.